Since the previous update of the ECDC Rapid Risk Assessment on MERS-CoV (30 June 2015), 13 new cases and seven deaths have been reported globally from South Korea (4 cases and 4 deaths), Saudi Arabia (8 cases and 3 deaths) and the Philippines who reported a travel-related MERS case related to travel in the Middle East on 6 July 2015.
This new publication from Novartis in collaboration with public health and academic researchers in Finland and the US adds to the evidence-base on how narcolepsy might have been triggered in genetically susceptible individuals.
Since the last epidemiological update on 15 June 2015, 25 additional cases and seven deaths in previously reported cases have been reported in South Korea. Health authorities in Thailand reported their first MERS-CoV case.
Since the last epidemiological update published by ECDC on 12 June 2015, 24 additional cases and six deaths in previously reported cases have been reported by South Korean authorities.
The World Health Organization (WHO) has agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2015-2016 influenza season.
On 4 February 2015, the National Health and Family Planning Commission (NHFPC) of China notified WHO of 83 additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus. Onset dates ranged from 20 December 2014 to 27 January 2015.
ECDC welcomes the Council Conclusions, as of 1 December 2014, and will continue to support the EU and its Member States in responding to the invitations for action described in these and previous Council conclusions.